Literature DB >> 17367266

Drug-induced splenic enlargement.

Andy Petroianu1.   

Abstract

Splenomegaly results from different abnormal conditions susceptible to drugs. Their diagnosis is based on a history of exposure to a drug before the spleen enlargement. This paper reviews studies on drugs that may induce to splenomegaly. Drugs may provoke the enlargement of the spleen by direct effect on splenic cells or as a side effect of disturbances in other organs, such as the liver, or systems, such as the haematoimmunological system. Some drugs provoke severe haemolysis associated with splenomegaly. Another cause of spleen increasing in size is the venous congestion due to liver disturbance with portal vein occlusion as side complications of drugs. All these drug side effects are usually transitory and splenomegaly disappears when the medication is discontinued. This is a complex problem that must be better studied to be understood in order to prevent its occurrence and to find the best treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17367266     DOI: 10.1517/14740338.6.2.199

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  Effects of a single intravenous bolus injection of alfaxalone on canine splenic volume as determined by computed tomography.

Authors:  Michelle M M Hasiuk; Fernando L Garcia-Pereira; Clifford R Berry; Gary W Ellison
Journal:  Can J Vet Res       Date:  2018-07       Impact factor: 1.310

2.  Shell-Free Copper Indium Sulfide Quantum Dots Induce Toxicity in Vitro and in Vivo.

Authors:  Joshua C Kays; Alexander M Saeboe; Reyhaneh Toufanian; Danielle E Kurant; Allison M Dennis
Journal:  Nano Lett       Date:  2020-02-05       Impact factor: 11.189

3.  Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin Inhibitors.

Authors:  Kate H Gartlan; Jagdish K Jaiswal; Matthew R Bull; Hedieh Akhlaghi; Vivien R Sutton; Kylie A Alexander; Karshing Chang; Geoffrey R Hill; Christian K Miller; Patrick D O'Connor; Jiney Jose; Joseph A Trapani; Susan A Charman; Julie A Spicer; Stephen M F Jamieson
Journal:  ACS Pharmacol Transl Sci       Date:  2022-05-31

4.  Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.

Authors:  Ganesh V Halade; Vasundhara Kain; Griffin M Wright; Jeevan Kumar Jadapalli
Journal:  J Leukoc Biol       Date:  2018-08-26       Impact factor: 4.962

5.  Potential protective effect of sunitinib after administration of diclofenac: biochemical and histopathological drug-drug interaction assessment in a mouse model.

Authors:  Jian Ren Tan; Srikumar Chakravarthi; John Paul Judson; Nagaraja Haleagrahara; Ignacio Segarra
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-05       Impact factor: 3.000

6.  Lactonic Sophorolipids Increase Tumor Burden in Apcmin+/- Mice.

Authors:  Breedge Callaghan; Helen Lydon; Sophie L K W Roelants; Inge N A Van Bogaert; Roger Marchant; Ibrahim M Banat; Christopher A Mitchell
Journal:  PLoS One       Date:  2016-06-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.